Emerging New Targets in Systemic Therapy for Malignant Pleural Mesothelioma
KM Yun, L Bazhenova - Cancers, 2024 - mdpi.com
Simple Summary Malignant pleural mesothelioma is an aggressive cancer that is not
surgically resectable for the majority of patients diagnosed with it. Chemotherapy or …
surgically resectable for the majority of patients diagnosed with it. Chemotherapy or …
[HTML][HTML] Antibody-drug conjugates combinations in cancer treatment
G Pretelli, K Mati, L Motta, A Stathis - Exploration of Targeted Anti …, 2024 - ncbi.nlm.nih.gov
Antibody-drug conjugates (ADCs) have emerged as a promising class of anticancer agents.
Currently, the Food and Drug Administration has granted approval to 12 compounds, with 2 …
Currently, the Food and Drug Administration has granted approval to 12 compounds, with 2 …